Heat-shock protein 90 inhibitors in cancer therapy: 17AAG and beyond

Author： Younes Anas   Georgakis Georgios V  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.1, Iss.2, 2005-04, pp. : 273-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of heat-shock protein 90 on cancer metastasis

By Tsutsumi Shinji   Beebe Kristin   Neckers Len  

Future Oncology, Vol. 5, Iss. 5, 2009-06 ,pp. : 679-688

Future Medicine

Access to resources Recommend Favorite

Heat Shock Protein 90 Inhibitors as Therapeutic Agents

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 3, 2012-09 ,pp. : 313-336

Bentham Science Publishers

Access to resources Recommend Favorite

Heat-shock protein expression in leukemia

By Sedlackova Lucie  

Tumor Biology, Vol. 32, Iss. 1, 2011-02 ,pp. : 33-44

Springer Publishing Company

Access to resources Recommend Favorite

Effect of a heat shock protein 90specific inhibitor on the proliferation and apoptosis induced by VEGFC in cervical cancer cells

By        

Experimental and Therapeutic Medicine, Vol. 8, Iss. 5, 2014-01 ,pp. : 1559-1564

Spandidos Publications

Access to resources Recommend Favorite

Expression of Tumor Antigens and Heat-Shock Protein 70 in Breast Cancer Cells After High-Intensity Focused Ultrasound Ablation

By Wu Feng   Wang Zhi-Biao   Cao You-De   Zhou Qiang   Zhang Ying   Xu Zhong-Lin   Zhu Xue-Qiang  

Annals of Surgical Oncology, Vol. 14, Iss. 3, 2007-03 ,pp. : 1237-1242

Springer Publishing Company

Access to resources Recommend Favorite